• LAST PRICE
    1.1400
  • TODAY'S CHANGE (%)
    Trending Up0.0100 (0.8850%)
  • Bid / Lots
    1.1300/ 27
  • Ask / Lots
    1.1800/ 43
  • Open / Previous Close
    1.1685 / 1.1300
  • Day Range
    Low 1.0000
    High 1.2900
  • 52 Week Range
    Low 0.2479
    High 4.7500
  • Volume
    681,439
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 1.13
TimeVolumeFEMY
09:32 ET6001.1685
09:36 ET50331.13
09:38 ET5041.16
09:39 ET4441.1301
09:43 ET10001.13
09:50 ET32001.15
09:54 ET107881.1901
09:56 ET17301.21
09:57 ET1050621.2155
09:59 ET13001.2101
10:01 ET85251.21
10:03 ET39641.21
10:06 ET2001.23
10:08 ET30641.2093
10:15 ET2001.2
10:17 ET23391.2238
10:21 ET50611.21
10:24 ET52191.23
10:26 ET96251.23
10:28 ET18681.23
10:30 ET776481.2485
10:32 ET23901.245
10:33 ET14001.25
10:35 ET79791.26
10:37 ET101781.275
10:39 ET46521.28
10:42 ET23451.29
10:44 ET195011.2599
10:46 ET52991.26
10:48 ET13201.265
10:51 ET23701.25
10:53 ET17311.2401
10:55 ET10061.245
11:00 ET20181.25
11:04 ET21521.24
11:08 ET1001.24
11:09 ET13001.25
11:11 ET12481.25
11:13 ET7201.2491
11:15 ET2001.245
11:20 ET21001.24
11:24 ET5001.245
11:33 ET26041.23
11:36 ET21001.235
11:38 ET70301.23
11:45 ET1291.23
11:47 ET1001.24
11:49 ET2001.23
11:54 ET1001.24
12:07 ET5081.2205
12:14 ET1001.23
12:27 ET1001.2399
12:30 ET1001.2299
12:34 ET8141.2294
12:38 ET226401.215
12:39 ET2001.215
12:43 ET1001.21
12:50 ET2168911.075
12:52 ET57601.11
12:54 ET96001.115
12:56 ET16001.12
12:57 ET21011.11
01:01 ET21501.125
01:03 ET172851.1212
01:06 ET2001.135
01:08 ET2001.15
01:12 ET12001.14
01:14 ET21131.135
01:15 ET6001.135
01:17 ET6061.14
01:19 ET15001.14
01:26 ET2301.1499
01:28 ET3001.14
01:32 ET1001.15
01:33 ET1751.1469
01:35 ET52651.13
01:37 ET2001.13
01:39 ET1001.13
01:42 ET2001.13
01:44 ET6001.1399
01:46 ET4541.13
01:50 ET2001.12
01:53 ET2001.13
01:57 ET2001.12
02:00 ET6001.13
02:06 ET2001.1306
02:08 ET2001.13
02:09 ET23001.125
02:11 ET8001.135
02:13 ET3001.14
02:15 ET2961.136
02:18 ET4001.1357
02:20 ET3001.13
02:22 ET2001.1301
02:24 ET2001.13
02:26 ET6001.14
02:27 ET1001.14
02:29 ET2001.1301
02:31 ET3001.13
02:33 ET2001.1301
02:36 ET1001.1405
02:40 ET2001.13
02:45 ET2001.13
02:47 ET11421.14
02:49 ET5001.1301
02:56 ET1001.135
02:58 ET5001.13
03:05 ET6001.12
03:12 ET27501.14
03:18 ET6391.14
03:20 ET109151.125
03:27 ET3001.11
03:30 ET1001.14
03:36 ET2001.11
03:38 ET4001.13
03:39 ET1001.13
03:41 ET3001.1214
03:43 ET11001.13
03:45 ET31081.125
03:50 ET62021.14
03:52 ET2661.13
03:56 ET26001.13
03:57 ET1001.1201
03:59 ET6631.14
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesFEMY
Femasys Inc
25.1M
-1.3x
---
United StatesCQCQ
MakingORG Inc
26.7M
-296.4x
---
United StatesXAIR
Beyond Air Inc
28.8M
-0.3x
---
United StatesORGS
Orgenesis Inc
21.3M
-0.4x
---
United StatesGVDI
Golden Valley Development Inc
20.5M
0.0x
---
United StatesNRXS
Neuraxis Inc
20.7M
-0.9x
---
As of 2024-07-26

Company Information

Femasys Inc. is a biomedical company. The Company is focused on addressing unmet needs of women worldwide with a broad portfolio of in-office, accessible, and innovative therapeutic and diagnostic solutions. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery targeting both fallopian tubes with a degradable biopolymer. FemaSeed is an artificial insemination infertility treatment. Its artificial insemination solution in development includes its FemaSeed product candidate for artificial insemination, which features single intrauterine directional delivery. The Company also developed a technology platform, namely FemEMB for tissue sampling intended to be marketed alongside its other women-specific medical products in the physician’s office setting.

Contact Information

Headquarters
3950 JOHNS CREEK COURT, SUITE 100SUWANEE, GA, United States 30024
Phone
770-500-3910
Fax
---

Executives

Non-Executive Independent Chairman of the Board
Charles Larsen
President, Chief Executive Officer, Director
Kathy Lee-Sepsick
Chief Financial Officer
Dov Elefant
Chief Operating Officer, Senior Vice President
Daniel Currie
Senior Vice President - Regulatory and Clinical Affairs
Christine Thomas

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$25.1M
Revenue (TTM)
$1.0M
Shares Outstanding
22.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-0.86
Book Value
$0.85
P/E Ratio
-1.3x
Price/Sales (TTM)
23.9
Price/Cash Flow (TTM)
---
Operating Margin
-1,423.04%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.